Atlas Trials

Hoth Therapeutics, Inc.

2 clinical trials · Sponsor

Sort:Newest firstOldest first

◉ Watch Hoth Therapeutics, Inc.

RecordFirmDate
Study to Investigate the Efficacy, Safety, and Tolerability of Topical HT-001 for the Treatment of Skin Toxicities Associated With Epidermal Growth Factor Receptor Inhibitors (NCT05639933)Hoth Therapeutics, Inc.2023-07-19
Safety, Tolerability, Pharmacokinetics and Efficacy of Twice Daily Application of Topical BioLexa in Adult Healthy Subjects and Patients With Mild to Moderate Atopic Dermatitis (NCT04544943)Hoth Therapeutics, Inc.2021-05-17

Track Hoth Therapeutics, Inc. automatically

Every clearance here is in the API, with alerts when new ones post.